VICI Properties Inc (VICI) Stock Price Today
Aura AI Summary
Key Stats
- $29.22BMarket Cap
- -Volume
- Real EstateSector
- $33.7852W High
- $25.9452W Low
- -Typical Hold Time
- $46.78BEnterprise Value
- 6.78%Div Yield
- -Trading Activity
Track VICI Properties Inc (VICI) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, VICI Properties Inc has traded between a low of $25.94 and a high of $33.78, highlighting its annual price range. Buy and sell VICI Properties Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About VICI Properties Inc
VICI Properties is an S&P 500 experiential real estate investment trust (REIT) that owns one of the largest portfolios of market-leading gaming, hospitality, and entertainment destinations, including Caesars Palace and MGM Grand. It utilizes a long-term, triple-net lease model to provide stable, inflation-protected income, serving as the primary landlord for the 'experience economy' while diversifying into non-gaming sectors like wellness, youth sports, and luxury resorts.
Most Recent News
Digital Realty backs Texas Governor Abbott's plan for responsible data center growth amid rising AI demand.
Digital Realty, the largest cloud- and carrier-neutral data center platform, supports Texas Governor Abbott's initiative for responsible and transparent data center investment in Texas. The company emphasizes collaboration with officials and communit...

Verisk Analytics CEO Lee Shavel sells 2,500 shares for $550,000.
Verisk Analytics CEO Lee Shavel has sold 2,500 shares of the company, generating $550,000 from the transaction. This sale may indicate personal portfolio adjustments or strategic financial planning by the CEO. Investors might watch for any further in...

Replimune's stock jumps after FDA approves its first skin cancer drug Tudriqev
Replimune Group Inc. received FDA approval for Tudriqev, its first drug targeting a difficult form of skin cancer, marking a major milestone for the biotech company. Despite earlier rejections and concerns over clinical data quality, the FDA granted ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.